Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Dec 7;6(1):e1255395. doi: 10.1080/2162402X.2016.1255395

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Author(s). Published with license by Taylor & Francis Group, LLC

This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.

PMC Copyright notice

Figure 3. — Timing of EBX treatment. (A) Polyp burden in 100-d-old Apc^Min mice following treatment with carrier protein (KLH) or peptide (EBX) at 7, 9, and 13 weeks following birth. (B) Polyp burden in 100-d-old Apc^Min mice born to females (n = 3) immunized with either carrier protein (KLH) or peptide (EBX). (C) ELISA analysis of IgG in milk isolated 10 d following birth from females immunized with either carrier protein (KLH) or peptide (EBX). Statistics: ^‡p < 0.001; **p < 0.01.